Literature DB >> 29383473

Response to risk of hydroxychloroquine retinopathy is not related to systemic lupus erythematosus or rheumatoid arthritis.

Nilufer Yesilirmak1, Hande Husniye Telek2, Gulten Sungur2, Yaprak Ozdemir3, Nesibe Karahan Yesil4, Firdevs Ornek2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29383473     DOI： 10.1007/s10633-018-9624-3

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN： 0012-4486            Impact factor:   2.379


× No keyword cloud information.
  4 in total

1.  The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy.

Authors:  Ronald B Melles; Michael F Marmor
Journal:  JAMA Ophthalmol       Date:  2014-12       Impact factor: 7.389

2.  Retinal toxicity related to hydroxychloroquine in patients with systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Hande Husniye Telek; Nilufer Yesilirmak; Gulten Sungur; Yaprak Ozdemir; Nesibe Karahan Yesil; Firdevs Ornek
Journal:  Doc Ophthalmol       Date:  2017-08-29       Impact factor: 2.379

3.  Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).

Authors:  Michael F Marmor; Ulrich Kellner; Timothy Y Y Lai; Ronald B Melles; William F Mieler
Journal:  Ophthalmology       Date:  2016-03-16       Impact factor: 12.079

4.  Unusual Fundus Autofluorescence Appearance in a Patient with Hydroxychloroquine Retinal Toxicity.

Authors:  Sleiman Abou-Ltaif
Journal:  Case Rep Ophthalmol       Date:  2015-06-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.